Navigation Links
YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU
Date:7/14/2011

Paris, 14 July 2011 Bristol-Myers Squibb today announced that the European Commission has approved YERVOY (ipilimumab) for the treatment of adult patients with previously-treated advanced melanoma.

YERVOY, an innovative immunotherapy, showed long-term survival in the treatment of patients with advanced melanoma in a randomised, double-blind Phase III study published in the New England Journal of Medicine in June 2010.(1) Based on the survival (Kaplan-Meier) curve, the 1 and 2-year estimated survival rates for patients treated with YERVOY were 46% and 24% respectively vs. 25% and 14% in the comparator arm with some patients alive at 3 and 4 years.

"With the approval of YERVOY physicians now have an important new option to offer to patients with metastatic melanoma. This is a chance of not just months but potentially 3 to 4 years of prolonged survival for some patients in the treatment of metastatic melanoma," comments Professor Alexander Eggermont, General Director, Institut Gustave Roussy, Paris, France. "There is hope that YERVOY's novel mode of action, together with the fact that the recommended complete course of treatment with YERVOY (3 mg/kg) includes 4 infusions over 3 months, could potentially change the way we treat patients with previously treated advanced melanoma. It is an example of what can be done through unleashing the power of one's own immune response."

Bristol-Myers Squibb will now work closely with local health authorities to expedite the availability of YERVOY across the European Union. Prior to approval, the Company provided ipilimumab to nearly 3,000 patients throughout Europe through Compassionate Use / Named Patient Programmes. The Company remains committed to helping ensure that appropriate patients who need YERVOY will receive it while the reimbursement process is finalised by the relevant authorities throughout Europe.

Ron Cooper, President Bristol-Myers Squibb Europe, stated: "With an aver
'/>"/>

Contact: Elzbieta Zawislak
elzbieta.zawislak@bms.com
33-615-523-580
TogoRun
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Rochester technology to enhance eyesight approved by FDA
2. FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds
3. New drug for use in bone scans approved
4. Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
5. First Patient Treated in U.S.-Approved Embryonic Stem Cell Trial
6. The Good Nite Lite Awarded the Parent Tested Parent Approved Seal
7. U.S. FDA Adds 25 New Firms to Import Alert for Promotion of Unapproved New Drugs According to FDAImports.com, LLC
8. doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions
9. Parent Tested Parent Approved Media Announces their Winning Products for the Summer 2010 Campaign
10. Expert Approved: FatWallet Guides Mother's Day Shoppers to the Best Deals Online
11. Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
(Date:4/17/2014)... less than 40 years away from a food shortage ... according to a top scientist at the U.S. Agency ... history, food production will be limited on a global ... said Dr. Fred Davies, senior science advisor for the ... as politically destabilizing by 2050 as energy issues are ...
(Date:4/17/2014)... whose work has transformed cancer care in Northern Ireland, ... Academy of Cancer Sciences., The Academy, which was launched ... distinguished oncologists and cancer researchers which aims to reduce ... , Professor Johnston, whose leadership has seen cancer survival ... the UK league table to near the top, has ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:Food shortages could be most critical world issue by mid-century 2
... Society for Radiation Oncology (ASTRO), the Association of Residents ... the 2011 Educator of the Year Award. , ARRO ... recognize outstanding teachers and mentors of radiation oncology residents. ... opportunity to select one faculty member from their program ...
... UCLA,s Jonsson Comprehensive Cancer Center have developed and ... and characterizes chemical compounds that can target the ... brain tumors. Glioblastoma is one of the ... 18 months. These brain cancers consist of two ...
... , MONDAY, Oct. 10 (HealthDay News) -- In the latest ... food, Swedish scientists report that eating chocolate seems to lower ... that women who had the highest consumption of chocolate -- ... percent reduced risk of stroke. "Cocoa contains flavonoids, which ...
... mother,s womb between the father,s biological goal to produce the ... through delivery might help explain preeclampsia, an often deadly disease ... yet small enough to pass through the birth canal. In ... these conflicting goals in balance. , The findings are ...
... Legs Syndrome, you may have a higher risk of developing ... Hypertension: Journal of the American Heart Association . RLS ... intense, unpleasant leg sensations, and an irresistible urge to move ... daytime drowsiness. It affects as many as 15 percent of ...
... it is a small study and more clinical trials ... result in a reduction in brain amyloid levels in ... Online First by Archives of Neurology , one ... suggests that the accumulation of amyloid-β (Aβ) peptides in ...
Cached Medicine News:Health News:ARRO honors 39 with Educator of the Year Award 2Health News:UCLA researchers develop new way to screen for brain cancer stem cell killers 2Health News:UCLA researchers develop new way to screen for brain cancer stem cell killers 3Health News:Chocolate Could Be Sweet Defense Against Stroke 2Health News:Chocolate Could Be Sweet Defense Against Stroke 3Health News:Battle between the placenta and uterus could help explain preeclampsia 2Health News:Restless legs syndrome may raise high blood pressure risk in middle-aged women 2Health News:Small study shows association between medication and reduction in brain amyloid levels related to AD 2
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... July 12 MedPro Imaging, a leading supplier ... been chosen by the Chicago Bears Football Club, Inc. to ... other health issues for the team during the upcoming 2010 ... Mobile Imaging Services division which offers mobile ultrasound services throughout ...
... July 12 Endo Pharmaceuticals (Nasdaq: ENDP ) today ... offer by its wholly owned subsidiary, HT Acquisition Corp., for all ... HTRN).  American Stock Transfer & Trust Company, the depositary for the ... , New York City time, on July 9, ...
Cached Medicine Technology:MedPro Imaging to Supply Mobile Ultrasound Diagnostics to Chicago Bears Players 2MedPro Imaging to Supply Mobile Ultrasound Diagnostics to Chicago Bears Players 3Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 2Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 3Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 4
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Medicine Products: